MedTrace Logo

Evaluation of an Eye Tracking Sensor to Detect Cannabis Impairment

NCT03994926 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2021-10-01

No results posted yet for this study

Summary

The purpose of this study is to determine if an eye tracking impairment sensor can detect cannabis-induced impairment after using cannabis.The overall objective is to correlate measures collected from the eye tracking sensor with measures related to cannabis impairment (e.g., plasma THC levels, self-reported cannabis subjective effects, cognitive effects).

Conditions

  • Cannabis Intoxication

Interventions

DEVICE

Virtual Reality Eye Tracking after smoking Cannabis - HTC Vive Pro-Eye

Device measures smooth eye pursuit and response to light flash after pt smokes cannabis

DRUG

Cannabis cigarette - 4.0% THC

smoked cannabis 4.0% THC

Sponsors & Collaborators

  • Battelle Memorial Institute

    lead OTHER

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-03
Primary Completion
2020-03-13
Completion
2020-03-13
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03994926 on ClinicalTrials.gov